Matinas BioPharma (NYSE:MTNB) CEO & Co-founder Jerry Jabbour joins Natalie Stoberman from the Proactive newsroom to discuss the company s latest growth and.
Form 424B3 NewAmsterdam Pharma Co streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
The growing demand for novel drugs, which hold potential for the treatment of previously untreatable intracellular targets has resulted in an adjacent and urgent need for efficient delivery
Main Street Financial Solutions LLC lowered its holdings in Matinas BioPharma Holdings, Inc. (NYSEAMERICAN:MTNB – Get Rating) by 100.0% in the fourth quarter, Holdings Channel reports. The firm owned 200 shares of the company’s stock after selling 400,626 shares during the quarter. Main Street Financial Solutions LLC’s holdings in Matinas BioPharma were worth $401,000 as […]
/PRNewswire/ The "Global Genetic Disorders Partnering 2016-2023: Deal trends, players and financials" report has been added to ResearchAndMarkets.com s.